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Galactosemia, an inborn error of metabolism, is transmitted as an autosomal, 
recessive gene (1-3), and is chemically characterized by a  defect in the enzyme 
Gal-l-P uridyl transferase (4). This results in the inability to convert galactose 
to glucose, and in the consequent accumulation  of Gal-l-P in the tissues (5). 
Possibly as a toxic manifestation of this accumulation (6), hepatosplenomegaly, 
cataracts,  mental  retardation,  convulsions,  jaundice,  gastrointestinal  dis- 
turbances, and death may supervene in affected infants in whom galactose has 
not  been  removed  from  the  diet. 
The metabolic pathways involved in galactose metabolism follow (7-10) :1 
(a) Gal  +  ATP  galact0kinase~Gal-l-P  W  ADP 
Gal-I-P uridyl 
(b) Gal-I-P  W  UDPGlu.  '  Glu-I-P  W  UDPGal 
transferase 
UDPGal-4-epimerase 
(0  UDPGal,  '  UDPGlu 
UDPGlu pyrophosphorylase  • 
(d)  Glu-l-P  W  UTP .  UDPGlu +  PP 
UDP  Gai pyrophosphorylase 
(e)  Gal-I-P +  UTP,  • UDPGal  +  PP 
* From the Department of Biophysics  Contribution No. 208) and from the Department 
of Pediatrics, University of Colorado Medical Center, Denver. This work was aided by a 
grant from The National Foundation and by a training grant, T1 GM 781-04, from the Na- 
tional Institute of General Medical Sciences. 
1  Symbols: Gal, galactose; ATP, adenosine triphosphate;  Gal-l-P, galactose-l-phosphate; 
Glu-I-P,  glucose-l-phosphate; UDPGal, uridine diphosphogalactose; UTP, uridine triphos- 
phate; PP, pyrophosphate. 
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The first three of these reactions are known to occur in red cells, but reaction e which 
has been demonstrated in other tissues, has not been shown in red cells (10). 
From the above reactions it ~s dear that a  block in reaction b unaccompanied by a 
large forward reaction in step e would result in an accumulation of Gal-I-P. 
Persons with galactosemia then may be characterized as Gal-I-P uridyl transferase 
mutants comparable to the galactose mutants of Escherichia  coli. In E. coli, however, 
mutants have  been found involving blocks in reactions a  and c  as well as  b  (11). 
Similar blocks have not been reported in mammals, possibly because they have not 
been recognized. However,  one patient has been reported  in whom a  galactokinase 
block  has  been  postulated  (12),  and  an  epimerase  block  has  been  described  in  L 
cells (13). 
It  seemed  of interest,  therefore,  to  adapt  a  method  previously utilized by 
Morse  (14)  for  the  investigation of  galactose  mutants  of E.  coli,  to  human 
erythrocytes  for  the  purpose  of  studying  galactokinase  and  Gal-l-P  uridyl 
transferase in persons varying in genotype with respect to galactose utilization. 
The method consists of incubating erythrocytes in the presence of galactose-1- 
C 14 and analyzing the distribution of the resulting C14-1abeled compounds. 
Method 
1.  The red blood cells in 0.75 cc of heparinized, freshly drawn blood are washed in the cold 
with a  buffer (10  -8 M tris in 0.14 ~  sodium chloride containing 50 mg per cent ,-glucose). 
Duplicate samples are prepared from each patient. Blood from an individual known to be 
normal is always run in parallel with a series of test bloods. 
2.  The washed red blood cells are reconstituted to their original volume by the addition 
of cold buffer. This suspension of erythrocytes may be refrigerated overnight. 
3.  To the suspension is added UDPGal (0.05 rag)  to act as a  carrier for the purpose of 
possibly trapping any radioactive UDPGal produced enzymatically, which might otherwise 
be lost either by subsequent enzymatic transformation or by non-specific processes  like ad- 
sorption to glassf and 0.25  microcurie D-galactose-l-C~4.  8 The tubes are placed in a  water 
bath at 37°C for exactly 2 minutes, then removed and plunged into an ice bath. 
4.  The tubes are centrifuged in the cold/or 2 minutes at  1500 P.P~ in an International 
clinical  centrifuge; the supernatant liquid is removed and the red blood cells are washed in the 
same cold buffer to which 50 mg per cent of D-galactose has been added. The washed cells are 
restored to original volume (0.75 cc) with cold, distilled water to induce hemolysis. The tube 
is then immersed in boiling water for 90 seconds to inactivate enzymes and precipitate pro- 
reins, and finally is centrifuged until the supernatant liquid is clear. 
5.  0.1  ml of the clear supernatant liquid is applied to Whatman No.  4  chromatograph 
paper (1 inch wide)  which has been previously washed in Leloir's ethanol-acetate solvent (1 
M sodium acetate pH 7.5, 30 cc; 95 per cent ethanol, 75 cc), and ascending paper chroma- 
tography is carried out in the same solvent. The dried papers are cut into strips 5 mm wide, 
using a semiautomatic paper-cutting device. 4  The strips are placed, in order, into consecutively 
numbered bottles of a scintillation counter.  5 Each bottle contains 10 cc of a mixture of PPO, 
Uridine 5r-diphosphogala~tose  sodium, Sigma Chemical Company, St. Louis. 
Specific activity 8.0 mc/mmole, Volk Radio-Chemical Company, Chicago. 
4  "Slide-n-cut," Safety Cutter Company, Menlo Park, California. 
5 Tri-carb liquid scintillation  spectrometer, Packard Instrument  Company, Inc., La Grange, 
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POPOP, and toluene (PPO, 2 gm; POPOP, 50 rag; toluene, 500 cc).S Graphs are then con- 
structed of the location of radioactivity on the chromatograph strips. The sites of radioac- 
tivity conform  to theR.F.'s  ~  for Gal (0.65), GaI-1-P (0.32), and UDPGal (0.18) originally de- 
termined by Leloir (7) for this solvent and confirmed by us. 
6. The ratio of the amount of radioactivity in the Gal-t-P position to that in the UDPGal 
• .  [GaI*-I-P  \ 
posxtlon  ~UD~  X  I00)  is  computed  as a measure  of the  relative  activity  of the trans- 
ferase  enzyme and  is  called  the  "R" value. 
In Figs. I to 3 are respectively  presented typical  radioactivity  distributions 
obtained from the chromatography of (a) a presumably normal subject,  (5) a 
patient with galactosernia,  and (c) a heterozygous carrier  of the galactosemic 
defect.  The corresponding "R" values are indicated. 
~XPEIU~a~NXAL RESULXS 
1.  Results  on Presumably  Normal Persons from  a  Random  Population.--lm 
order to obtain a  baseline for this test, 37 randomly chosen people from the 
general population were subjected to the procedure. Some of these were anony- 
mous blood donors. The  "R" values obtained  are  presented  in Table  I  and 
reveal a mean and standard deviation of 80 and 12.4, respectively. In addition, 
12 consecutive determinations were carried out during a period of 3 weeks on a 
single,  presumably normal individual.  The latter  data presented  in Table  II 
show a  mean and  standard  deviation  which  are  reasonably close to  the  re- 
spective values obtained on the random population. The data of Table I reveal 
that only 3  of the 37 individuals tested  differ from the mean by 2 standard 
deviations or more. Of these,  1 was pregnant, and it is conceivable that this 
condition may affect  the  test.  The  other  2  values  were  obtained  on  blood 
samples from unidentified  donors. The fact that  these  2  values deviated  by 
approximately 3 standard deviations from the mean is not as significant as it 
might seem, since these particular determinations were carried out during the 
early period of development of the methodology before the measures needed 
to insure maximum reliability of the results had been identified. If a new mean 
were computed without these 3 values, it would be appreciably closer to that 
found in the repeated determinations on the same person, as listed in Table II. 
However, for the present all of the data have been retained in order to treat 
them  most conservatively.  Further  assays  on  larger  groups  of  presumably 
normal persons are planned in  order to fix  more definitely the frequency of 
occurrence of deviations of various magnitudes in a  random population. 
2.  Results on Patients with Galactosemia.--Three patients with galactosemia 
were available and have been tested. As would be expected, no demonstrable 
e PPO, 2,5  diphenyloxazole; POPOP, 1,4 bis-2-(5-phenyloxazolyl)-benzene,  Packard In- 
strument Company, Inc., LaGrange, Illinois; toluene, scintillation grade, Matheson Cole- 
man and Bell, Cincinatti. 
R.F.: This term is used in chromatography to locate the  position of  a  molecule on 
the chromatograph paper "relative to the solvent front." 362  ENZYME  ASSAY  IN"  GALACTOSEM~C  DEFECT 
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UDPGal  was formed in any case  (cf.  Fig. 2).  The  sensitivity of the  test was 
.such that even an amount of UDPGal one-fiftieth as great as the  Gal-l-phos- 
phate  produced  could  have  been  detected.  Hence,  the  "R"  value  for  all of 
these  patients is  at least 5000. 
3.  Results on Known Carriers of the Galaclosemia Defect.--Six known carriers 
TABLE I 
"R"  Values of Erythroeytes of Healthy Individuals  in the General Population  (Controls) 
66  73  82 
66  74  83 
67  74  83 
67  74  84 
67  74  84 
68  76  89 
68  76  92 
69  78  93 
72  78  94 
73  81  99 
73  81  103" 
73  81  111~ 
119~ 
Mean ffi 80 
sv =  12.4 
96 per cent confidence limits 
-- 55 to 105 
* Subject was pregnant. 
:~ These two determinations were done early in the procedures and were on individuals 
who could not be rechecked. No values on normal persons have since been that high. 
TABLE II 
Variability in One Individual 
12 determinations 
Mean ...................................................  74 
96 per'cent'confidence'~l~is.'.iiiiiiiiiiiiiiiiiiiiiiiiiiill  9  56 to 92 
"R" values of 12 determinations on erythrocytes performed on 6 different days. 
of the recessive defect, i.e. the parents of the patients listed above, were avail- 
able and tested by this procedure (of.  Fig. 3). Values of the ratio are presented 
in Table IlL  This group reveals a  mean value of "R"  of 170,  which is more 
than twice that of the normal population. The standard deviation of the group 
of known carriers is 20.5, so that the significance of these results is obvious. This 
distinct difference between the values obtained from heterozygous carriers and 
members of the population at large suggests that the current procedure might 
serve as an unambiguous means for detection of heterozygous carriers. 
4.  Results  on  Siblings  of Galactosemia  Patients  and  on  Relatives  of Known 366  ENZYME  ASSAY IN GALACTOSEMIC DEFECT 
Carriers.--As  a  final group of subjects,  the siblings,  cousins, and aunts of the 
galactosemic patients were also tested,  in order to determine whether this test 
could reveal the presence of the recessive defect in the clinically normal persons 
of families where the genetic defect occurs. The data obtained (Table IV) reveal 
that the relatives  are clearly divided into two distinct  groups, one resembling 
the  normal population,  and  the other resembling  the known carriers in  their 
response to this procedure. These results are made clear in Fig. 4, where all of 
the  data  from  the  three  groups  of  disease-free  subjects  are  analyzed,  It  is 
TABLE III 
"R"  Values for Erythrocytes of Carriers (Parents of Galactosemic Children) 
1.  Mr. B ............................  155 
2.  Mrs. B ............................  162 
3.~Mr. O ............................  206 
4.  Mrs. O ............................  ]  181 
i 
5.  Mr. W ............................  [  158 
i  6.  Mrs. W ...........................  I  155 
r 
Mean  =  170 
sD -- 20.5 
96 per cent confidence limits  -- 
129 to 211 
TABLE IV 
"R"  Values of Erythrocytes of Relatives of Carriers 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
°61  167  . 
210  Careers 
222j 
92 
70 
87 
78 
71 
particularly significant that in the total of 52 persons who have been examined, 
not  1  has  yielded  a  result  falling  in  the  borderline  region  with  "R"  values 
between  120 and 154, even when the 2 questionable,  high values from Table I 
are included. The 9 relatives of the carriers are unequivocally identified by this 
procedure as to whether or not they possess a defective gene for the transferase 
enzyme. While these studies will be extended to larger groups, the data already 
available  appear  to offer promise  of distinguishing  carriers  of this  particular 
gene with a higher precision than has been hitherto possible. 
5.  Results  on Cells in  Tissue Culture.--Results  on Hela cells and  cells from 
skin  of a  patient  with  galactosemia  grown  in  tissue  culture  reveal  that  the 
method can also be utilized  on somatic cells  in  culture.  Further  studies  with 
these are in progress. ARTHIYRROBINSON  367 
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DISCUSSION 
It is realized that in this solvent system it is impossible to differentiate the 
R.F.'s  of  the  three  galactose  compounds from  those  of glucose,  glucose-l- 
phosphate, and uridine diphosphoglucose. Activity of the epimerase enzyme 
may,  in  fact,  transform  some of  the  labeled uridine diphosphogalactose to 
uridine diphosphoglucose.  For  this  reason  we  have  stated  that  the  sites  of 
radioactivity are  compatible  with  those of the  galactose compounds.  While 
they might  contain varying amounts of the  glucose compounds also,  these 
substances presumably also require integrity of step b in the metabolic sequence 
presented earlier, and hence would serve as well as UDPGal to indicate presence 
of a block. Thus the resulting ratios appear to characterize well the three groups 
of genotypes in relation to galactose metabolism. Studies of the detailed met- 
abolic events in galactose metabolism are continuing. 
Several methods have been developed for the determination of transferase 
enzymes in human erythrocytes. The three methods which to date have sepa- 
rated  the  three  groups  most  distinctly are  the  UDPGlu  consumption  test 
(15-17); a  test which measures the output of C140~ of erythrocytes incubated 
with Cl~-labeled  galactose  (18);  and a  manometric assay (19)  of the oxygen 
consumed in metabolism of a  measured amount of galactose. In all of these, 
and particularly in the latter method, there is definite overlapping of the values 
obtained from the different groups of human subjects. In addition, the methods 
tend to be somewhat complex. 
The method here described has the advantage of simplicity and reproduci- 
bility;  lack  of  any  demonstrated  overlap  between  normals,  heterozygous 
carriers, and homozygous persons with the disease; and direct measurement of 
the  immediate reaction product of the  blocked reaction b so  that galactose 
metabolism by other pathways is ruled out. Finally, the present method gives 
information on the presence of kinase as well as transferase enzyme. 
This test offers the hope of identifying with reasonable reliability the hetero- 
zygous carriers in families of patients affected with galactosemia, and so is of 
value in genetic counseling. In addition, it furnishes a means for determining 
the frequency of the gene defect in a  large population, without the  serious 
assumptions implicit in the estimates based on the frequency of occurrence of 
the homozygous state in which the disease is present. 
SUMMARY 
A simple, rapid, and direct method for measuring the activities of the galac- 
tokinase and  Gal-I-P  uridyl  transferase enzymes in  human  erythrocytes is 
presented. 
The method has  been  applied  to  measurement of enzyme activities in  a 
group of 37 presumably normal persons, 3 patients with galactosemia, 6 known ARTHUR ROBINSON  369 
heterozygous carriers of the defect, and 9 relatives of carriers. In every case the 
test unambiguously identified the individual's status as normal, heterozygotic 
carrier, or homozygously defective. 
Use of the test in genetic counseling and  genetic epidemological studies  is 
discussed. 
The author wishes to thank Dr. T. T. Puck and Dr. M. L. Morse for their helpful interest 
during this investigation. 
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